Vas (Dr. Vass Nairosif)
Biopharmaceutical executive and physician-scientist serving as CEO of Novartis, discussing company strategy, radioligand therapy, R&D priorities, and AI in drug development during the interview.
Best podcasts with Vas (Dr. Vass Nairosif)
Ranked by the Snipd community
Jan 14, 2026 • 44min
Mad Money w/ Jim Cramer 1/13/26
In this episode, Jim Cramer sits down with several industry leaders. Dr. Vass Nairosif, CEO of Novartis, shares insights on portfolio simplification and the future of radioligand therapy. Robert Bradway from Amgen discusses his company's innovative obesity drug, highlighting long-term efficacy. Dr. Leonard Schleifer of Regeneron talks about groundbreaking treatments like Dupixent and their advancements in cardiovascular risk. Jason Holler of Cardinal Health explores operational improvements and specialty distribution, emphasizing a strong financial outlook.
